Funder
Sapienza Università di Roma
Dani di Giò
Regione Lazio
Ministero della Salute
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Sarshar, M., Behzadi, P., Scribano, D., Palamara, A. T. & Ambrosi, C. Acinetobacter baumannii: an ancient commensal with weapons of a pathogen. Pathogens 10, 387 (2021).
2. Vivo, A. et al. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study. BMC Infect. Dis. 22, 491 (2022).
3. Stracquadanio, S. et al. Acinetobacter baumannii and Cefiderocol, between cidality and adaptability. Microbiol. Spectr. 10, e02347–02322 (2022).
4. Nie, D. et al. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J. Biomed. Sci. 27, 1–8 (2020).
5. Ansari, H., Tahmasebi-Birgani, M., Bijanzadeh, M., Doosti, A. & Kargar, M. Study of the immunogenicity of outer membrane protein A (ompA) gene from Acinetobacter baumannii as DNA vaccine candidate in vivo. Iran. J. basic Med. Sci. 22, 669 (2019).